Skip to search formSkip to main contentSkip to account menu

amotosalen hydrochloride

The hydrochloride salt form of amotosalen, a synthetic psoralen and light-activated DNA, RNA crosslinking agent, with protective activity against… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

amotosalen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units.
2016
2016
Pathogen‐reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola‐specific neutralizing antibodies
Ebola virus disease is a public health emergency of international concern, and enormous efforts are being made in the development… 
Highly Cited
2008
Highly Cited
2008
Quantitative analysis of DNA interstrand cross-links and monoadducts formed in human cells induced by psoralens and UVA irradiation.
Upon exposure to UVA light, psoralens can induce DNA interstrand cross-links (ICLs), which can block DNA replication and… 
Review
2006
Review
2006
Risks of fresh frozen plasma and platelets.
Both fresh frozen plasma (FFP) and platelets are heavily used in massive transfusion. Although FFP can partially correct abnormal… 
2005
2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S‐59) and ultraviolet A light
BACKGROUND: The standard treatment for thrombotic thrombocytopenic purpura (TTP) is plasma exchange with fresh‐frozen plasma (FFP… 
2004
2004
Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model
BACKGROUND:  A photochemical treatment (PCT) process utilizing amotosalen hydrochloride and long wavelength UVA light has been… 
Highly Cited
2002
Highly Cited
2002
Pharmacokinetic study of FFP photochemically treated with amotosalen (S‐59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin
BACKGROUND : To date, no clinical trials have characterized FFP infusion efficacy, and infusion still carries infectious risk… 
Review
2001
Review
2001
Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma.
Review
2001
Review
2001
Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components.
  • N. Luban
  • Seminars in hematology
  • 2001
  • Corpus ID: 29604121
Review
2001
Review
2001
Inactivation of cytomegalovirus in platelet concentrates using Helinx technology.
  • L. Lin
  • Seminars in hematology
  • 2001
  • Corpus ID: 25911405
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)